544 related articles for article (PubMed ID: 11440203)
1. Type A gamma-aminobutyric acid (GABAA) receptor subunits and benzodiazepine binding: significance to clinical syndromes and their treatment.
Smith TA
Br J Biomed Sci; 2001; 58(2):111-21. PubMed ID: 11440203
[TBL] [Abstract][Full Text] [Related]
2. Native gamma-aminobutyric acid type A receptors from rat hippocampus, containing both alpha 1 and alpha 5 subunits, exhibit a single benzodiazepine binding site with alpha 5 pharmacological properties.
Araujo F; Ruano D; Vitorica J
J Pharmacol Exp Ther; 1999 Sep; 290(3):989-97. PubMed ID: 10454469
[TBL] [Abstract][Full Text] [Related]
3. Cerebellar GABAA receptor selective for a behavioural alcohol antagonist.
Lüddens H; Pritchett DB; Köhler M; Killisch I; Keinänen K; Monyer H; Sprengel R; Seeburg PH
Nature; 1990 Aug; 346(6285):648-51. PubMed ID: 2166916
[TBL] [Abstract][Full Text] [Related]
4. Functional comparison of the role of gamma subunits in recombinant human gamma-aminobutyric acidA/benzodiazepine receptors.
Wafford KA; Bain CJ; Whiting PJ; Kemp JA
Mol Pharmacol; 1993 Aug; 44(2):437-42. PubMed ID: 8102787
[TBL] [Abstract][Full Text] [Related]
5. Selective labelling of diazepam-insensitive GABAA receptors in vivo using [3H]Ro 15-4513.
Pym LJ; Cook SM; Rosahl T; McKernan RM; Atack JR
Br J Pharmacol; 2005 Nov; 146(6):817-25. PubMed ID: 16184188
[TBL] [Abstract][Full Text] [Related]
6. The GABAA-BZR complex as target for the development of anxiolytic drugs.
Trincavelli ML; Da Pozzo E; Daniele S; Martini C
Curr Top Med Chem; 2012; 12(4):254-69. PubMed ID: 22204488
[TBL] [Abstract][Full Text] [Related]
7. Altered gabaa receptor subunit and splice variant expression in rats treated with chronic intermittent ethanol.
Petrie J; Sapp DW; Tyndale RF; Park MK; Fanselow M; Olsen RW
Alcohol Clin Exp Res; 2001 Jun; 25(6):819-28. PubMed ID: 11410716
[TBL] [Abstract][Full Text] [Related]
8. [3H]RY 80: A high-affinity, selective ligand for gamma-aminobutyric acidA receptors containing alpha-5 subunits.
Skolnick P; Hu RJ; Cook CM; Hurt SD; Trometer JD; Liu R; Huang Q; Cook JM
J Pharmacol Exp Ther; 1997 Nov; 283(2):488-93. PubMed ID: 9353361
[TBL] [Abstract][Full Text] [Related]
9. [GABA(A) benzodiazepine receptors and epilepsy].
Sieghart W
Wien Klin Wochenschr; 1990 Mar; 102(7):197-201. PubMed ID: 2160756
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the abundance and subunit composition of GABAA receptor subtypes in the cerebellum of alpha1-subunit-deficient mice.
Ogris W; Lehner R; Fuchs K; Furtmüller B; Höger H; Homanics GE; Sieghart W
J Neurochem; 2006 Jan; 96(1):136-47. PubMed ID: 16277610
[TBL] [Abstract][Full Text] [Related]
11. From ion currents to genomic analysis: recent advances in GABAA receptor research.
Rabow LE; Russek SJ; Farb DH
Synapse; 1995 Nov; 21(3):189-274. PubMed ID: 8578436
[TBL] [Abstract][Full Text] [Related]
12. Recombinant extracellular domain of the three major subunits of GABAA receptor show comparable secondary structure and benzodiazepine binding properties.
Shi H; Tsang SY; Tse MK; Xu Z; Xue H
Protein Sci; 2003 Nov; 12(11):2642-6. PubMed ID: 14573876
[TBL] [Abstract][Full Text] [Related]
13. Importance of a novel GABAA receptor subunit for benzodiazepine pharmacology.
Pritchett DB; Sontheimer H; Shivers BD; Ymer S; Kettenmann H; Schofield PR; Seeburg PH
Nature; 1989 Apr; 338(6216):582-5. PubMed ID: 2538761
[TBL] [Abstract][Full Text] [Related]
14. Benzodiazepine/barbiturate/GABA receptor-chloride ionophore complex in a genetic model for generalized epilepsy.
Olsen RW; Wamsley JK; Lee RJ; Lomax P
Adv Neurol; 1986; 44():365-78. PubMed ID: 3010677
[TBL] [Abstract][Full Text] [Related]
15. Differentiating the role of gamma-aminobutyric acid type A (GABAA) receptor subtypes.
Wafford KA; Macaulay AJ; Fradley R; O'Meara GF; Reynolds DS; Rosahl TW
Biochem Soc Trans; 2004 Jun; 32(Pt3):553-6. PubMed ID: 15157182
[TBL] [Abstract][Full Text] [Related]
16. Covalent modification of GABAA receptor isoforms by a diazepam analogue provides evidence for a novel benzodiazepine binding site that prevents modulation by these drugs.
Baur R; Tan KR; Lüscher BP; Gonthier A; Goeldner M; Sigel E
J Neurochem; 2008 Sep; 106(6):2353-63. PubMed ID: 18643789
[TBL] [Abstract][Full Text] [Related]
17. Cloning of cDNA sequences encoding human alpha 2 and alpha 3 gamma-aminobutyric acidA receptor subunits and characterization of the benzodiazepine pharmacology of recombinant alpha 1-, alpha 2-, alpha 3-, and alpha 5-containing human gamma-aminobutyric acidA receptors.
Hadingham KL; Wingrove P; Le Bourdelles B; Palmer KJ; Ragan CI; Whiting PJ
Mol Pharmacol; 1993 Jun; 43(6):970-5. PubMed ID: 8391122
[TBL] [Abstract][Full Text] [Related]
18. 3,4-Dihydronaphthalen-1(2H)-ones: novel ligands for the benzodiazepine site of alpha5-containing GABAA receptors.
Szekeres HJ; Atack JR; Chambers MS; Cook SM; Macaulay AJ; Pillai GV; MacLeod AM
Bioorg Med Chem Lett; 2004 Jun; 14(11):2871-5. PubMed ID: 15125950
[TBL] [Abstract][Full Text] [Related]
19. Altered pharmacology of synaptic and extrasynaptic GABAA receptors on CA1 hippocampal neurons is consistent with subunit changes in a model of alcohol withdrawal and dependence.
Liang J; Cagetti E; Olsen RW; Spigelman I
J Pharmacol Exp Ther; 2004 Sep; 310(3):1234-45. PubMed ID: 15126642
[TBL] [Abstract][Full Text] [Related]
20. Benzodiazepine-insensitive mice generated by targeted disruption of the gamma 2 subunit gene of gamma-aminobutyric acid type A receptors.
Günther U; Benson J; Benke D; Fritschy JM; Reyes G; Knoflach F; Crestani F; Aguzzi A; Arigoni M; Lang Y; Bluethmann H; Mohler H; Lüscher B
Proc Natl Acad Sci U S A; 1995 Aug; 92(17):7749-53. PubMed ID: 7644489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
